{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/135640525"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology and cardiovascular disease treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, gastroenterology, neurology and other conditions." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "businesswire.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/262250014"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/135640525"] } } }
